Myocarditis: Current Trends in Diagnosis and Treatment

  title={Myocarditis: Current Trends in Diagnosis and Treatment},
  author={Jared W. Magnani and G. William Dec},
Myocarditis is clinically and pathologically defined as “inflammation of the myocardium.” Despite its rather clear-cut definition, the classification, diagnosis, and treatment of myocarditis continue to prompt considerable debate. The more routine use of endomyocardial biopsy has helped to better define the natural history of human myocarditis and to clarify clinicopathological correlations. Clinical presentations of the disease range from nonspecific systemic symptoms (fever, myalgias… 

Figures and Tables from this paper

Epidemiology and Prognosis of Myocarditis and dilated Cardiomyopathy: Predictive Value of Clinical Parameters and Biopsy Findings

Although endomyocardial biopsy remains the “gold standard” for establishing the diagnosis, cardiac magnetic resonance imaging with gadolinium enhancement has rapidly emerged as the screening procedure of choice.

Current Diagnosis and Management of Myocarditis

Patients who can be managed by conventional therapy or who require specific treatment based on underlying etiology, such as antiviral or intravenous immunoglobulin infusion are directed to endomyocardial biopsy.

Viral myocarditis—diagnosis, treatment options, and current controversies

This Review explores the pathophysiology, natural history, and modes of diagnosis of myocarditis, as well as evidence-based treatment strategies, and indicates the landscape of therapies for this elusive disease is poised to improve.

The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature

There is no consensus regarding aetiology, clinical presentation, diagnosis, and management of myocarditis in pediatric patients, and emerging evidence to support investigations such as serum N-terminal B-type natriuretic peptide levels, as well as cardiac magnetic resonance imaging as adjuncts to the clinical diagnosis.

Myocarditis in Childhood: An Update on Etiology, Diagnosis and Management

It has been shown that most common known cause of dilated cardiomyopathy is myocarditis (46%), and several mechanisms were postulated for progression of myocardococcal inflammation to dilated heart failure and sudden death, including direct viral injury.

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure

The aim of this review is to approach the recently discovered facets of paediatric myocarditis regarding its progression to dilated cardiomyopathy.


Findings from recent clinical trials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical course despite standard medical care and might improve with a short course of immunosuppression.

Republished: Pathogenesis and diagnosis of myocarditis

Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests.

Acute myocarditis and sudden death in the young: Case report

The case of a young girl dying suddenly due to acute lymphocytic myocarditis is presented, and the characterization of the virus trough Polimerase Chain Reaction is recommended.

Pathogenesis and diagnosis of myocarditis

Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests.



Introduction to Clinical Myocarditis

The more routine use of endomyocardial biopsy has helped better define the natural history of human myocarditis and clarify clinicopathologic correlations.

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

Fulminant myocarditis is a distinct clinical entity with an excellent long-term prognosis and Aggressive hemodynamic support is warranted for patients with this condition.

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome.

It is concluded that many cases of unexplained dilated cardiomyopathy result from myocarditis, and the efficacy of immunosuppressive treatment must still be established.

Predictors of Disease Course in Patients With Acute Myocarditis

Serum levels of soluble Fas and soluble Fas ligand levels at initial presentation appear to be a good serological marker to predict the prognosis of acute myocarditis.

Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?

Patients with heart failure due to IDC should be treated with conventional heart failure regimens, including diuretics, angiotensin-converting enzyme (ACE) inhibitors, digitalis, β-blockers, vasodilators, aldosterone antagonists, and other effective medications and technology.

Advances in the understanding of myocarditis.

The objective of this article is to better define myocarditis for both clinicians and clinical scientists by setting it in the framework of 3 phases of disease, in which the viral stage is reviewed, the autoimmune phase is examined and the remodeling processes are considered.

Giant Cell Myocarditis: Diagnosis and Treatment

A randomized trial of immunosuppression including muromonab-CD3, cyclosporine, and steroids is underway to confirm and extend data from a Lewis rat model and from observational human studies suggest that giant cell myocarditis is mediated by T lymphocytes and may respond to treatment aimed at attenuating T cell function.

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.

  • C. Kawai
  • Biology, Medicine
  • 1999
The rather discouraging results obtained to date with immunosuppressive agents in the treatment of viral myocarditis indicated the importance of sparing neutralizing antibody production, which may be controlled by B cells, and raised the possibility of promising developments in immunomodulating therapy.